
William P. Neuder
Examiner (ID: 10341)
| Most Active Art Unit | 3672 |
| Art Unit(s) | 3672, 2899, 3625, 3642, 3506 |
| Total Applications | 4583 |
| Issued Applications | 4090 |
| Pending Applications | 166 |
| Abandoned Applications | 332 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20192259
[patent_doc_number] => 20250268969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/251611
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251611 | OPHTHALMIC COMPOSITION | Oct 4, 2021 | Pending |
Array
(
[id] => 17426828
[patent_doc_number] => 20220054536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/494180
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494180
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494180 | NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS | Oct 4, 2021 | Abandoned |
Array
(
[id] => 18784790
[patent_doc_number] => 20230372424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => ANTIVIRAL ACTIVE CINNAMON EXTRACT AND PROCESS
[patent_app_type] => utility
[patent_app_number] => 18/246911
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246911
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246911 | ANTIVIRAL ACTIVE CINNAMON EXTRACT AND PROCESS | Sep 30, 2021 | Pending |
Array
(
[id] => 17341376
[patent_doc_number] => 20220007707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => CANNABIS CALIBRATION SYSTEM-DERIVED PRODUCTS AND METHOD OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 17/485447
[patent_app_country] => US
[patent_app_date] => 2021-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/485447 | CANNABIS CALIBRATION SYSTEM-DERIVED PRODUCTS AND METHOD OF MAKING SAME | Sep 25, 2021 | Pending |
Array
(
[id] => 17342162
[patent_doc_number] => 20220008493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD FOR INCREASING THC/CBD CONTENT IN A CANNABIS PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/485446
[patent_app_country] => US
[patent_app_date] => 2021-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/485446 | METHOD FOR INCREASING THC/CBD CONTENT IN A CANNABIS PRODUCT | Sep 25, 2021 | Pending |
Array
(
[id] => 18970359
[patent_doc_number] => 20240050451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => PRECISION CANNABINOID THERAPY FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/246613
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246613 | PRECISION CANNABINOID THERAPY FORMULATIONS AND METHODS OF USE | Sep 23, 2021 | Pending |
Array
(
[id] => 19232119
[patent_doc_number] => 20240189310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291
[patent_app_type] => utility
[patent_app_number] => 17/478117
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478117
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478117 | PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 | Sep 16, 2021 | Abandoned |
Array
(
[id] => 19608083
[patent_doc_number] => 12156942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Sustained delivery of therapeutic agents to an eye compartment
[patent_app_type] => utility
[patent_app_number] => 17/475528
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15945
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/475528 | Sustained delivery of therapeutic agents to an eye compartment | Sep 14, 2021 | Issued |
Array
(
[id] => 17297730
[patent_doc_number] => 20210393569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Taxane Particles and Their Use
[patent_app_type] => utility
[patent_app_number] => 17/467655
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/467655 | Taxane Particles and Their Use | Sep 6, 2021 | Abandoned |
Array
(
[id] => 17290852
[patent_doc_number] => 20210386691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => Oral Dosage Forms of Ketamine
[patent_app_type] => utility
[patent_app_number] => 17/460476
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460476 | Method for treatment of depression with oral dosage forms of ketamine | Aug 29, 2021 | Issued |
Array
(
[id] => 18707595
[patent_doc_number] => 20230330172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION
[patent_app_type] => utility
[patent_app_number] => 18/023119
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023119
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023119 | COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION | Aug 24, 2021 | Pending |
Array
(
[id] => 18690953
[patent_doc_number] => 20230321125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES INCLUDING ANTI-TUMOR EFFECTS
[patent_app_type] => utility
[patent_app_number] => 18/022372
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 423
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022372
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022372 | COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES INCLUDING ANTI-TUMOR EFFECTS | Aug 19, 2021 | Abandoned |
Array
(
[id] => 17242062
[patent_doc_number] => 20210361805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => ANTI-ODOR COMPOSITIONS, STRUCTURES HAVING ANTI-ODOR CHARACTERISTICS, METHODS OF MAKING THE ANTI-ODOR COMPOSITIONS AND THE STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 17/398413
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/398413 | Anti-odor compositions, structures having anti-odor characteristics, methods of making the anti-odor compositions and the structures | Aug 9, 2021 | Issued |
Array
(
[id] => 18596014
[patent_doc_number] => 20230270805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/018473
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018473 | A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF | Aug 2, 2021 | Pending |
Array
(
[id] => 19279982
[patent_doc_number] => 20240216455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => NON-STEROIDAL TOPICAL COMPOSITION AND METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/916806
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916806 | NON-STEROIDAL TOPICAL COMPOSITION AND METHOD THEREOF | Jul 22, 2021 | Pending |
Array
(
[id] => 18626625
[patent_doc_number] => 20230285422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH MUTATIONS IN THE SYNGAPI GENE
[patent_app_type] => utility
[patent_app_number] => 18/005848
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005848
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005848 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH MUTATIONS IN THE SYNGAPI GENE | Jul 14, 2021 | Pending |
Array
(
[id] => 18647839
[patent_doc_number] => 20230293614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/016189
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016189
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016189 | COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES | Jul 12, 2021 | Pending |
Array
(
[id] => 18691056
[patent_doc_number] => 20230321249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => DRUG-CLAY MINERAL COMPLEX CONTAINING PHOSPHOLIPID AND ORAL ADMINISTRATION COMPOSITION INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 18/013919
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013919
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013919 | DRUG-CLAY MINERAL COMPLEX CONTAINING PHOSPHOLIPID AND ORAL ADMINISTRATION COMPOSITION INCLUDING SAME | Jun 30, 2021 | Pending |
Array
(
[id] => 17512583
[patent_doc_number] => 11291701
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-05
[patent_title] => Orally disintegrating, sublingual and buccal formulations
[patent_app_type] => utility
[patent_app_number] => 17/353149
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3706
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353149 | Orally disintegrating, sublingual and buccal formulations | Jun 20, 2021 | Issued |
Array
(
[id] => 18656199
[patent_doc_number] => 20230302079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/011335
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011335 | SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS | Jun 20, 2021 | Pending |